Key result
Intramyocardial acellular ECM particles lack reported cardiac functional outcomes post-MI.
Why the study?
Does intramyocardial injection of lab-grown 3D acellular ECM particles improve cardiac function in a post-MI murine model?
Does intramyocardial injection of lab-grown 3D acellular ECM particles improve cardiac function in a post-MI murine model?
Answers are grounded in this paper and cite their sources.
Lab-grown 3D acellular ECM particles from human MSCs may offer a novel, less immunogenic approach to improving cardiac function post-myocardial infarction.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Broadwin et al. (2024) studied Myocardial ischemia / postmyocardial infarction. Lab-grown human three-dimensional acellular extracellular matrix (ECM) particles vs. Normal saline was evaluated on Cardiac function.
Synapse has enriched 10 related papers. Consider them for comparative context: